Congress Appropriated $101 Million. HHS Spent $500,000. Five Days Remain in the Fiscal Year

There is a number in federal grantmaking that should never appear in a sentence with a date this late in the fiscal year. The number is 0.5 percent.

Congress appropriated $101 million for the Teen Pregnancy Prevention Program in fiscal year 2026. As of this week, according to a letter signed by 92 members of the House and Senate, the Department of Health and Human Services has spent roughly $500,000 of it. Fiscal year 2026 ends at midnight on September 30 — five days from the letter's delivery.

This is not a story about a program being cut. Congress funded TPP. The President signed the bill. The money is sitting in a Treasury account. What happened instead is a sequence of administrative moves — terminations, a rewritten competition, litigation, and a stalled award decision — that between them converted a fully appropriated program into an unobligated balance racing a statutory clock. Understanding that sequence matters far beyond adolescent health, because the mechanics are portable to any discretionary program a future administration wants to slow without asking Congress for anything.

The Timeline, Reconstructed

2010. Congress creates the Teen Pregnancy Prevention Program, housed at the HHS Office of Population Affairs within the Office of the Assistant Secretary for Health. The design is unusual for federal health programming: OPA funds only models that have cleared a rigorous evidence review, and funds replication of those models in new settings and populations.

June 2026. OPA abruptly terminates the existing grant portfolio. Roughly 50 recipients — nonprofits, universities, and local health departments — lose funding. Most were in year three of five-year project periods, meaning staff hired, curricula licensed, school district memoranda signed, and evaluation cohorts mid-enrollment.

June 10, 2026. OPA posts AH-TPS-26-001, a competition to establish a National Training Center for Teen Pregnancy Prevention: $1.5 million, one award, applications due July 10.

June 23, 2026. OPA posts AH-TP1-26-001, "Replicating Effective Teen Pregnancy Prevention (TPP) Programs." Total program funding: $63,400,000. Expected awards: 52. Award range: $900,000 to $2,000,000. Cooperative agreement. No cost share. Applications due July 23, 2026 at 6:00 p.m. ET. Anticipated project start date: September 30, 2026.

Read those last two lines together. HHS set a 30-day application window and put the anticipated start date on the last day of the fiscal year. That is not an accident of scheduling — it is the tell that the agency knew the obligation deadline was the binding constraint.

The new requirements. The replacement NOFO did not simply re-run the old competition. Recipients would be required to incorporate sexual risk avoidance education conveying the "health and social benefits of avoiding sexual activity during adolescence," and to deliver two modules on female and male reproductive health emphasizing connections between hormonal health and sleep, nutrition, physical activity, and stress management — the agency's "body literacy" framing. Applicants also had to align activities with Office of the Assistant Secretary for Health priorities.

August 2026. Judge Christopher Cooper of the U.S. District Court for the District of Columbia rules that HHS cannot impose those requirements on the TPP program. The decision on whether terminated grantees must be reinstated remains pending.

September 25, 2026. Ninety-two lawmakers, led by Rep. Judy Chu of California through the Democratic Women's Caucus, write to HHS. "Withholding these funds deprives teens across the U.S. of vital resources and threatens to unwind decades of progress," the letter states. Chu's framing is jurisdictional rather than ideological: "This is a bipartisan program created by Congress with clear intent of supporting evidence-based education." HHS did not respond to press inquiries before publication.

Meanwhile the FY2027 budget request proposes eliminating TPP entirely.

Why September 30 Is the Whole Story

Most HHS discretionary grant appropriations are one-year money: the agency has until the end of the fiscal year of appropriation to obligate the funds. Obligation is the legally binding commitment — for grants, generally the signed Notice of Award. Money that is neither obligated nor explicitly made available for a longer period lapses back and requires a fresh appropriation to spend.

That is why the arithmetic in the congressional letter is so pointed. A competition that closed on July 23 with an anticipated start of September 30 is a competition whose entire value depends on award notices going out in the final week of September. If they do not, then the peer review panels, the 52 planned awards, and the $63.4 million are all work product attached to money that no longer exists.

There is a second reading worth holding open, and honest analysis requires naming it: it is possible HHS issues a tranche of awards between now and September 30 and the unobligated figure falls sharply in the final days. Agencies routinely obligate enormous sums in the last week of September — the phenomenon is well documented across NIH and NSF. What is unusual here is not late obligation. It is late obligation on a program whose existing grantees were terminated in June, whose replacement competition drew a court order in August, and whose FY2027 budget line is proposed for zero. Each of those facts independently raises the probability that award notices do not go out.

Either way, applicants and terminated grantees are in the same position: they cannot influence the obligation decision, and they can influence almost everything else.

What Terminated Grantees Should Do This Week

Preserve the reinstatement record. Judge Cooper's reinstatement decision is pending. If it lands in your favor, the agency will need to restore an award to a specific scope and budget — and the practical question will be whether you can still execute it. Document, with dates, what your organization lost between June and now: staff separated, subawards cancelled, school district agreements lapsed, evaluation cohorts broken, licensed curriculum seats forfeited. A reinstatement order is worth far more to an organization that can hand the project officer a current, executable workplan than to one that has to rebuild from memory.

Stephanie McDowell, executive director of Bridgercare in Montana, described the operational reality to NPR plainly: "We can't sustain an education program at scale serving 21 counties without funding." Kristin Fairholm of EyesOpenIowa said it has been "disheartening for us to have to tear everything down." Both statements are also, usefully, evidence.

Do closeout properly even if you expect to be reinstated. Unspent funds, final federal financial reports, and equipment disposition all have deadlines that run independent of litigation. An unclean closeout is a risk-designation problem on every future federal application your organization files, and it is entirely self-inflicted.

Separate the two claims in your own head. "The termination was unlawful" and "the FY2026 money lapsed" are different questions with different remedies. A court can order reinstatement; a court cannot manufacture an appropriation. If the money lapses, the fight moves to FY2027 appropriations language — which is where the 92-signature letter is really aimed.

What This Means for Everyone Else Holding a Federal Grant

The TPP sequence is a template, and it is worth learning as one.

A recompete can be a delay mechanism. Terminating awards and issuing a new competition with rewritten programmatic requirements consumes months. If the new requirements are then enjoined, the agency has spent the fiscal year and obligated nothing. Whether or not that was the intent here, it is the observable outcome — and it is reproducible.

"Anticipated start date" is a diagnostic. When a NOFO's anticipated start date sits on the last day of the fiscal year, the funds are almost certainly one-year money with no slack. That tells you two things: the agency has no margin for an award delay, and your own start-up assumptions should not include a ramp period.

Priority language is a real allocation signal. AH-TP1-26-001 gave preference to organizations not currently funded and never funded under the opportunity. For a program whose incumbent portfolio had just been terminated, that is a deliberate redistribution of a mature grantee base toward new entrants. If you are an incumbent in any program and you see never-funded priority language appear in a recompete, read it as a warning about your renewal odds, not as boilerplate.

Eligibility in the TPP NOFOs was genuinely broad. State, county, city, and tribal governments; public and private institutions of higher education; independent school districts; nonprofits with and without 501(c)(3) status; tribal organizations; faith-based organizations; small businesses; and legally recognized consortiums registered in SAM.gov. Any future reissue is likely to carry the same breadth, which means a wide set of organizations should be watching the FY2027 line even though it is proposed for elimination. Programs slated for zero in a budget request are restored by appropriators more often than most applicants assume — the TCUP line at NSF was proposed for a cut from $16.5 million to $7.1 million and largely restored.

Diversify against obligation risk specifically, not just award risk. Most grant diversification advice addresses the possibility of not winning. The TPP cohort won, executed for two years, and still lost the money. The structural defense is a funding mix where no single federal program carries more than a recoverable share of payroll, and a cash reserve sized to the gap between a termination notice and either reinstatement or an orderly wind-down. Our analysis of the five ways federal grants get killed after Congress funds them walks through the other mechanisms in the same family, and the NIH year-end obligation cliff shows what the same September 30 arithmetic looks like at scale.

The Part That Should Worry Applicants Most

The strongest argument in the congressional letter is not about teen pregnancy. It is about who decides.

Congress appropriated a specific sum for a specific program with an expressed preference for evidence-based models. An agency terminated the portfolio, substituted different programmatic requirements, lost in court on those requirements, and arrived at the end of the fiscal year having obligated half a percent of the appropriation. Whatever one thinks of the underlying policy, the process outcome is that a line item enacted in statute produced almost no grants.

For anyone who builds an organization around federal funding, that is the finding to internalize. The appropriation is necessary but not sufficient. The obligation is the event. Until a Notice of Award is signed, a congressional line item is a probability, and the distance between the two can be measured in a single fiscal year of an organization's payroll.

Check the Office of Population Affairs funding page and your Grants.gov workspace daily through September 30 if you applied under AH-TP1-26-001. If award notices issue, they will issue with almost no warning, and the start date on them will be immediate.